Covered recipient · General Payments record
KARLA J AU YEUNG
Allopathic & Osteopathic Physicians Pediatrics Pediatric Gastroenterology
General Payments · PY2018–2024
$3,058.77
- Reported across 112 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,098.71 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $697.32 | 27 |
| Ipsen Biopharmaceuticals, Inc | $125.00 | 1 |
| Mirum Pharmaceuticals, Inc. | $115.36 | 2 |
| Rhythm Pharmaceuticals, Inc. | $49.43 | 2 |
| GENZYME CORPORATION | $36.46 | 1 |
| Regeneron Healthcare Solutions, Inc. | $30.22 | 1 |
| QOL Medical, LLC | $23.82 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $21.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.06 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251465 | CMS |
| ABBVIE INC. | $22.59 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251467 | CMS |
| ABBVIE INC. | $20.99 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251469 | CMS |
| ABBVIE INC. | $16.52 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251471 | CMS |
| ABBVIE INC. | $13.86 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251473 | CMS |
| ABBVIE INC. | $125.00 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251475 | CMS |
| ABBVIE INC. | $19.04 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251477 | CMS |
| ABBVIE INC. | $20.80 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251479 | CMS |
| ABBVIE INC. | $16.91 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251481 | CMS |
| ABBVIE INC. | $0.69 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251483 | CMS |
| ABBVIE INC. | $18.33 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251485 | CMS |
| ABBVIE INC. | $22.54 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251487 | CMS |
| ABBVIE INC. | $18.76 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251489 | CMS |
| ABBVIE INC. | $20.37 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251491 | CMS |
| ABBVIE INC. | $125.00 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251493 | CMS |
| ABBVIE INC. | $15.11 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251495 | CMS |
| ABBVIE INC. | $21.88 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251497 | CMS |
| ABBVIE INC. | $23.42 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251499 | CMS |
| ABBVIE INC. | $17.76 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251501 | CMS |
| ABBVIE INC. | $6.79 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251503 | CMS |
| ABBVIE INC. | $23.21 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251505 | CMS |
| ABBVIE INC. | $21.76 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251507 | CMS |
| ABBVIE INC. | $16.34 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251509 | CMS |
| ABBVIE INC. | $15.52 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251511 | CMS |
| ABBVIE INC. | $23.92 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251513 | CMS |
| ABBVIE INC. | $18.88 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251515 | CMS |
| ABBVIE INC. | $16.27 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251517 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $21.10 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147022714 | CMS |
| GENZYME CORPORATION | $36.46 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139946705 | CMS |
| Ipsen Biopharmaceuticals, Inc | $125.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091980503 | CMS |
| Mirum Pharmaceuticals, Inc. | $91.99 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123323151 | CMS |
| Mirum Pharmaceuticals, Inc. | $23.37 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123323153 | CMS |
| QOL Medical, LLC | $23.82 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728580 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.22 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114002270 | CMS |
| Rhythm Pharmaceuticals, Inc. | $25.59 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141480226 | CMS |
| Rhythm Pharmaceuticals, Inc. | $23.84 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141480224 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.